Filing Details
- Accession Number:
- 0001179110-18-008436
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-06-13 15:30:52
- Reporting Period:
- 2018-06-12
- Accepted Time:
- 2018-06-13 15:30:52
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1235007 | Endocyte Inc | ECYT | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1509415 | P Christopher Leamon | 3000 Kent Ave, Suite A1-100 West Lafayette IN 47906 | Vice President Of Research | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2018-06-12 | 13,089 | $15.06 | 130,381 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Represents the sale of 13,089 shares in multiple transactions, ranging in price from $15.0000 to $15.1850, resulting in a weighted-average sale price per share of $15.0552. The reporting person will provide, upon request by SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range. The shares were sold pursuant to a written plan as specified in Rule 10b5-1(c) of the Securities Exchange Act of 1934.
Billionaire Hedge Funds
